Left ventricular assist device implantation and concomitant mitral valve surgery: A systematic review and meta-analysis.
LVAD
mechanical circulatory support
mitral valve
mitral valve surgery
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
12 Oct 2023
12 Oct 2023
Historique:
revised:
29
08
2023
received:
16
06
2023
accepted:
21
09
2023
medline:
12
10
2023
pubmed:
12
10
2023
entrez:
12
10
2023
Statut:
aheadofprint
Résumé
The management of concomitant valvular lesions in patients undergoing left ventricular assist device (LVAD) implantation remains a topic of debate. This systematic review and meta-analysis aimed to evaluate the existing evidence on postoperative outcomes following LVAD implantation, with and without concomitant MV surgery. A systematic database search was conducted as per PRISMA guidelines, of original articles comparing LVAD alone to LVAD plus concomitant MV surgery up to February 2023. The primary outcomes assessed were overall mortality and early mortality, while secondary outcomes included stroke, need for right ventricular assist device (RVAD) implantation, postoperative mitral valve regurgitation, major bleeding, and renal dysfunction. The meta-analysis included 10 studies comprising 32 184 patients. It revealed that concomitant MV surgery during LVAD implantation did not significantly affect overall mortality (OR:0.83; 95% CI: 0.53 to 1.29; p = 0.40), early mortality (OR:1.17; 95% CI: 0.63 to 2.17; p = 0.63), stroke, need for RVAD implantation, postoperative mitral valve regurgitation, major bleeding, or renal dysfunction. These findings suggest that concomitant MV surgery appears not to confer additional benefits in terms of these clinical outcomes. Based on the available evidence, concomitant MV surgery during LVAD implantation does not appear to have a significant impact on postoperative outcomes. However, decision-making regarding MV surgery should be individualized, considering patient-specific factors and characteristics. Further research with prospective studies focusing on specific patient populations and newer LVAD devices is warranted to provide more robust evidence and guide clinical practice in the management of valvular lesions in LVAD recipients.
Sections du résumé
BACKGROUND
BACKGROUND
The management of concomitant valvular lesions in patients undergoing left ventricular assist device (LVAD) implantation remains a topic of debate. This systematic review and meta-analysis aimed to evaluate the existing evidence on postoperative outcomes following LVAD implantation, with and without concomitant MV surgery.
METHODS
METHODS
A systematic database search was conducted as per PRISMA guidelines, of original articles comparing LVAD alone to LVAD plus concomitant MV surgery up to February 2023. The primary outcomes assessed were overall mortality and early mortality, while secondary outcomes included stroke, need for right ventricular assist device (RVAD) implantation, postoperative mitral valve regurgitation, major bleeding, and renal dysfunction.
RESULTS
RESULTS
The meta-analysis included 10 studies comprising 32 184 patients. It revealed that concomitant MV surgery during LVAD implantation did not significantly affect overall mortality (OR:0.83; 95% CI: 0.53 to 1.29; p = 0.40), early mortality (OR:1.17; 95% CI: 0.63 to 2.17; p = 0.63), stroke, need for RVAD implantation, postoperative mitral valve regurgitation, major bleeding, or renal dysfunction. These findings suggest that concomitant MV surgery appears not to confer additional benefits in terms of these clinical outcomes.
CONCLUSION
CONCLUSIONS
Based on the available evidence, concomitant MV surgery during LVAD implantation does not appear to have a significant impact on postoperative outcomes. However, decision-making regarding MV surgery should be individualized, considering patient-specific factors and characteristics. Further research with prospective studies focusing on specific patient populations and newer LVAD devices is warranted to provide more robust evidence and guide clinical practice in the management of valvular lesions in LVAD recipients.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
Références
Schmitto JD, Krabatsch T, Damme L, Netuka I. Less invasive HeartMate 3 left ventricular assist device implantation. J Thorac Dis. 2018;10:S1692-S1695.
McGee E, Danter M, Strueber M, Mahr C, Mokadam NA, Wieselthaler G, et al. Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: the LATERAL clinical trial. J Heart Lung Transplant. 2019;38:344-351.
Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019;38:114-126.
Wang TS, Hernandez AF, Felker GM, Milano CA, Rogers JG, Patel CB. Valvular heart disease in patients supported with left ventricular assist devices. Circ Heart Fail. 2014;7:215-222.
Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail. 2004;10:285-291.
Noly P-E, Duggal N, Jiang M, Nordsletten D, Bonini M, Lei I, et al. Role of the mitral valve in left ventricular assist device pathophysiology. Front Cardiovasc Med. 2022;9:9.
Kanwar MK, Rajagopal K, Itoh A, Silvestry SC, Uriel N, Cleveland JC Jr, et al. Impact of left ventricular assist device implantation on mitral regurgitation: an analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020;39:529-537.
Pal JD, Klodell CT, John R, Pagani FD, Rogers JG, Farrar DJ, et al. Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. Circulation. 2009;120:S215-S219.
John R, Naka Y, Park SJ, Sai-Sudhakar C, Salerno C, Sundareswaran KS, et al. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014;147:581-589.
Pawale A, Itagaki S, Parikh A, Pinney SP, Adams DH, Anyanwu AC. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2019;157:1841-1848.e1.
Kato TS, Chokshi A, Singh P, Khawaja T, Cheema F, Akashi H, et al. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail. 2011;4:546-553.
Gulati G, Ruthazer R, Denofrio D, Vest AR, Kent D, Kiernan MS. Understanding longitudinal changes in pulmonary vascular resistance after left ventricular assist device implantation. J Card Fail. 2021;27:552-559.
Ammirati E, Musca F, Cannata A, Garascia A, Verde A, Pacher V, et al. Limited changes in severe functional mitral regurgitation and pulmonary hypertension after left ventricular assist device implantation: a clue to consider concurrent mitral correction? Int J Cardiol. 2013;167:e35-e37.
Fukuhara S, Takeda K, Chiuzan C, Han J, Polanco AR, Yuzefpolskaya M, et al. Concomitant aortic valve repair with continuous-flow left ventricular assist devices: results and implications. J Thorac Cardiovasc Surg. 2016;151:201-210.e2.
Han J, Takeda K, Takayama H, Kurlansky PA, Mauro CM, Colombo PC, et al. Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device. J Thorac Cardiovasc Surg. 2016;151:520-527.e1.
Choi JH, Luc JGY, Moncho Escrivá E, Phan K, Rizvi SSA, Patel S, et al. Impact of concomitant mitral valve surgery with LVAD placement: systematic review and meta-analysis. Artif Organs. 2018;42:1139-1147.
Tanaka A, Onsager D, Song T, Cozadd D, Kim G, Sarswat N, et al. Surgically corrected mitral regurgitation during left ventricular assist device implantation is associated with low recurrence rate and improved midterm survival. Ann Thorac Surg. 2017;103:725-733.
Stulak JM, Tchantchaleishvili V, Haglund NA, Davis ME, Schirger JA, Cowger JA, et al. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2015;34:718-723.
Schreiber C, Dieterlen M-T, Garbade J, Borger MA, Sieg F, Spampinato R, et al. Validation of mitral regurgitation reversibility in patients with HeartMate 3 LVAD implantation. Artif Organs. 2022;46:106-116.
Dobrovie M, Spampinato RA, Efimova E, da Rocha E Silva JG, Fischer J, Kuehl M, et al. Reversibility of severe mitral valve regurgitation after left ventricular assist device implantation: single-Centre observations from a real-life population of patients. Eur J Cardiothorac Surg. 2018;53:1144-1150.
Goodwin M, Nemeh HW, Borgi J, Paone G, Morgan JA. Resolution of mitral regurgitation with left ventricular assist device support. Ann Thorac Surg. 2017;104:811-818.
Morgan JA, Brewer RJ, Nemeh HW, Murthy R, Williams CT, Lanfear DE, et al. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation. ASAIO J. 2012;58:574-577.
Arjomandi Rad A, Kapadia S, Zubarevich A, Nanchahal S, van den Eynde J, Vardanyan R, et al. Prognostic value of mitral regurgitation in patients undergoing left ventricular assist device deployment: a systematic review and meta-analysis. Artif Organs. 2023;47:273-289.
Jain R, Truby LK, Topkara VK. Residual mitral regurgitation in patients with left ventricular assist device support - an INTERMACS analysis. J Heart Lung Transplant. 2022;41:1638-1645.
Zubarevich A, Szczechowicz M, Arjomandi Rad A, Osswald A, Papathanasiou M, Luedike P, et al. Impact of severe mitral regurgitation on postoperative outcome after durable left-ventricular assist device implantation. Artif Organs. 2022;46:953-963.
Loforte A, Nersesian G, Lewin D, Lanmueller P, Gliozzi G, Stein J, et al. Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset. Eur J Cardiothorac Surg. 2023;63(2):ezad013.
Kassis H, Cherukuri K, Agarwal R, Kanwar M, Elapavaluru S, Sokos GG, et al. Significance of residual mitral regurgitation after continuous flow left ventricular assist device implantation. JACC Heart Fail. 2017;5:81-88.
Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care. 2010;14:R169.
Takeda K, Naka Y, Yang JA, Uriel N, Colombo PC, Jorde UP, et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant. 2014;33:141-148.
Park I, Cho YH, Chung SR, Jeong DS, Sung K, Kim WS, et al. Temporary right ventricular assist device insertion via left thoracotomy after left ventricular assist device implantation. Korean J Thorac Cardiovasc Surg. 2019;52:105-108.
Bravo CA, Navarro AG, Dhaliwal KK, Khorsandi M, Keenan JE, Mudigonda P, et al. Right heart failure after left ventricular assist device: from mechanisms to treatments. Front Cardiovasc Med. 2022;9:9.
Burke MA, Givertz MM. Assessment and Management of Heart Failure after Left Ventricular Assist Device Implantation. Circulation. 2014;129:1161-1166.
Lo Coco V, de Piero ME, Massimi G, Chiarini G, Raffa GM, Kowalewski M, et al. Right ventricular failure after left ventricular assist device implantation: a review of the literature. J Thorac Dis. 2021;13:1256-1269.
Sugiura T, Kurihara C, Kawabori M, Critsinelis AC, Wang S, Civitello AB, et al. Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: a single-center experience. J Thorac Cardiovasc Surg. 2019;158:1083-1089.e1.
Sandoval E, Singh SK, Carillo JA, Baldwin ACW, Ono M, Anand J, et al. Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion†. Interact Cardiovasc Thorac Surg. 2017;25:620-623.
Rodenas-Alesina E, Brahmbhatt DH, Rao V, Salvatori M, Billia F. Prediction, prevention, and management of right ventricular failure after left ventricular assist device implantation: a comprehensive review. Front Cardiovasc Med. 2022;9:9.
Kiernan MS, Grandin EW, Brinkley M, Kapur NK, Pham DT, Ruthazer R, et al. Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation. Circ Heart Fail. 2017;10:e003863.
Briasoulis A, Yokoyama Y, Kuno T, Ueyama H, Shetty S, Alvarez P, et al. In-hospital outcomes of left ventricular assist device implantation and concomitant valvular surgery. Am J Cardiol. 2020;132:87-92.
Willey JZ, Gavalas MV, Trinh PN, Yuzefpolskaya M, Reshad Garan A, Levin AP, et al. Outcomes after stroke complicating left ventricular assist device. J Heart Lung Transplant. 2016;35:1003-1009.
Cornwell WK, Ambardekar AV, Tran T, Pal JD, Cava L, Lawley J, et al. Stroke incidence and impact of continuous-flow left ventricular assist devices on cerebrovascular physiology. Stroke. 2019;50:542-548.
Robertson JO, Naftel DC, Myers SL, Tedford RJ, Joseph SM, Kirklin JK, et al. Concomitant mitral valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: an INTERMACS database analysis. J Heart Lung Transplant. 2018;37:79-88.
Kawabori M, Kurihara C, Conyer RT, Critsinelis AC, Sugiura T, Rosengart T, et al. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation. J Artif Organs. 2019;22:91-97.
Coffin ST, Waguespack DR, Haglund NA, Maltais S, Dwyer JP, Keebler ME. Kidney dysfunction and left ventricular assist device support: a comprehensive perioperative review. Cardiorenal Med. 2015;5:48-60.
Axtell AL, Fiedler AG, Melnitchouk S, D'Alessandro DA, Villavicencio MA, Jassar AS, et al. Correlation of cardiopulmonary bypass duration with acute renal failure after cardiac surgery. J Thorac Cardiovasc Surg. 2020;159:170-178.e2.
Cotts WG, McGee EC, Myers SL, Naftel DC, Young JB, Kirklin JK, et al. Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS registry. J Heart Lung Transplant. 2014;33:682-688.
Loyaga-Rendon RY, Kazui T, Acharya D. Antiplatelet and anticoagulation strategies for left ventricular assist devices. Ann Transl Med. 2021;9:521.
Kitada S, Kato TS, Thomas SS, Conwell SD, Russo C, di Tullio MR, et al. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation. J Heart Lung Transplant. 2013;32:897-904.
Cruz Rodriguez JB, Chatterjee A, Pamboukian SV, Tallaj JA, Joly J, Lenneman A, et al. Persistent mitral regurgitation after left ventricular assist device: a clinical conundrum. ESC Heart Fail. 2021;8:1039-1046.
Bhagra SK, Pettit S, Parameshwar J. Cardiac transplantation: indications, eligibility and current outcomes. Heart. 2019;105:252-260.
Fam NP, Ross HJ, Verma S. Mitral clip-looking back and moving forward. Curr Opin Cardiol. 2016;31:169-175.